Table 3 Pearson's correlations between MusiQoL and SF-36, and the 14 self-reported symptom scales
MusiQoL dimensions | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
SF-36 dimensions | ADL | PWB | RFr | SPT | RFa | RHCS | SSL | COP | REJ | Index |
Physical functioning | 0.729** | 0.203** | 0.087 | 0.311** | 0.178** | 0.217** | 0.195** | 0.282** | 0.248** | 0.496** |
Social functioning | 0.515** | 0.347** | 0.212** | 0.441** | 0.178** | 0.198** | 0.275** | 0.373** | 0.222** | 0.541** |
Role - physical | 0.603** | 0.409** | 0.078 | 0.514** | 0.181** | 0.177** | 0.118 | 0.315** | 0.300** | 0.551** |
Role - emotional | 0.443** | 0.443** | 0.099 | 0.527** | 0.115 | 0.126 | 0.164* | 0.489** | 0.274** | 0.559** |
Mental health | 0.383** | 0.665** | 0.241** | 0.504** | 0.310** | 0.145* | 0.389** | 0.654** | 0.465** | 0.760** |
Vitality | 0.688** | 0.577** | 0.157* | 0.550** | 0.258** | 0.214** | 0.354** | 0.532** | 0.364** | 0.699** |
Bodily pain | 0.431** | 0.392** | 0.064 | 0.471** | 0.149* | 0.180** | 0.157* | 0.283** | 0.219** | 0.463** |
General health | 0.542** | 0.347** | 0.128 | 0.360** | 0.116 | 0.200** | 0.265** | 0.450** | 0.247** | 0.521** |
14-symptom scales | ADL | PWB | RFr | SPT | RFa | RHCS | SSL | COP | REJ | Index |
Lack of sensation in touch | -0.295** | -0.057 | 0.070 | -0.112 | 0.068 | 0.126 | -0.160 | 0.062 | -0.019 | -0.100 |
Lack of sensation in position | -0.332** | -0.087 | 0.109 | -0.192* | 0.030 | 0.063 | -0.134 | -0.066 | -0.030 | -0.173 |
Involuntary body movements | -0.433** | -0.083 | 0.040 | -0.133 | -0.073 | -0.018 | 0.001 | -0.213* | -0.105 | -0.249* |
Vibration in legs or arms | -0.462** | -0.185* | -0.060 | -0.274** | -0.083 | -0.092 | -0.083 | -0.204* | -0.167 | -0.348** |
Weakness in limbs | -0.575** | -0.106 | -0.047 | -0.214** | -0.031 | -0.048 | 0.000 | -0.147 | -0.149 | -0.242** |
Tingling in limbs | -0.329** | -0.132 | 0.025 | -0.246** | -0.040 | -0.071 | -0.010 | -0.067 | -0.127 | -0.272** |
Inability to swallow | -0.054 | -0.155 | -0.011 | -0.056 | -0.232 | -0.080 | -0.202 | -0.279* | -0.052 | -0.269* |
Involuntary eye movements | -0.215* | -0.064 | 0.020 | -0.205 | 0.102 | 0.082 | -0.046 | -0.102 | 0.032 | -0.151 |
Visual problems | -0.311** | -0.185* | 0.051 | -0.423** | 0.062 | -0.062 | -0.138 | -0.087 | -0.124 | -0.321** |
Problems concentrating | -0.425** | -0.364** | -0.114 | -0.587** | -0.050 | -0.112 | -0.134 | -0.323** | -0.236** | -0.522** |
Difficulty concentrating | -0.326** | -0.224* | -0.235* | -0.395** | -0.048 | -0.060 | 0.001 | -0.234* | -0.388** | -0.422** |
Fatigue | -0.553** | -0.222** | -0.075 | -0.336** | -0.004 | -0.034 | -0.077 | -0.303** | -0.184* | -0.373** |
Urinary incontinence | -0.404** | -0.118 | -0.074 | -0.220* | -0.078 | -0.019 | -0.212* | -0.058 | -0.050 | -0.239* |
Bowel incontinence | -0.274* | -0.190 | -0.020 | -0.291** | -0.058 | -0.113 | -0.088 | -0.046 | -0.114 | -0.182 |